Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3582]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
High tumour immune cell levels may help screen HER2-positive breast cancer...
Dr Edith Perez - Mayo Clinic, Rochester, USA
High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
12 Dec 2014
CLL at ASH 2014: Expert discussion
Prof John Gribben and Prof Stephan Stilgenbauer
CLL at ASH 2014: Expert discussion ( Prof John Gribben and Prof Stephan Stilgenbauer )
12 Dec 2014
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of...
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014
BOLERO-1 reports HER2-positive breast cancer latest PFS data
Prof Sara Hurvitz - University of California, Los Angeles, USA
BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014
Impact of adding bevacizumab to presurgery chemo for triple-negative breast...
Dr William Sikov - Women and Infants Hospital, Providence, USA
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )
12 Dec 2014
Fulvestrant improves survival over anastrozole for patients with advanced...
Prof John Robertson - Royal Derby Hospital, Derby, UK
Fulvestrant improves survival over anastrozole for patients with advanced breast cancer ( Prof John Robertson - Royal Derby Hospital, Derby, UK )
12 Dec 2014
Progression-free survival results from BOLERO-1 trial
Prof Sara Hurvitz - University of California, Los Angeles, USA
Progression-free survival results from BOLERO-1 trial ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014
Impact of adding bevacizumab to presurgery chemo for triple-negative breast...
Dr William Sikov - Women and Infants Hospital, Providence, USA
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )
11 Dec 2014
Best of ASH 2014
Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert...
Best of ASH 2014 ( Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele )
8 Dec 2014
ASH 2014: Highlights in CLL from ASH 2014
Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger
ASH 2014: Highlights in CLL from ASH 2014 ( Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger )
8 Dec 2014
Ibrutinib as a single agent and in combination with dexamethasone showed anti...
Dr Ravi Vij - Washington University School of Medicine, St Louis, USA
Ibrutinib as a single agent and in combination with dexamethasone showed anti-tumour activity in multiple myeloma ( Dr Ravi Vij - Washington University School of Medicine, St Louis, USA )
8 Dec 2014
Hope for avoiding chemo in patients with Hodgkins lymphoma
Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy
Hope for avoiding chemo in patients with Hodgkins lymphoma ( Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy )
8 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation